CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,200 enrolled
Drug / intervention
WeChat mobile mini-applicationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04754139
NCT04754139N/ACompleted
CompareCT.gov

A Promotion and Implementation Project of HIV Pre-Exposure Prophylaxis Among High Risk Population

University of Chicago·interventional·Posted Feb 15, 2021·Updated Oct 3, 2024

In Brief

A clinical study evaluating WeChat mobile mini-application for HIV Preexposure Prophylaxis. Completed, enrolled 1,200 participants across 2 sites.

Detailed Summary

This study aims to use a social media mini-application-enabled intervention to successfully promote the initiation and persistence of pre-exposure prophylaxis (PrEP) among at-risk people 18 years and above (including men who have sex with men (MSM), transgender women, sex workers, and other key populations) in Wuhan and Guangzhou, China.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Preexposure Prophylaxis
CountriesChina
CollaboratorsGilead Sciences, Guangzhou 8th People's Hospital, Social Entrepreneurship to Spur Health, Zhongnan Hospital

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 15, 2021
Enrollment StartSep 24, 2021
Primary CompletionSep 30, 2024
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 5.4 years ago

Interventions

WeChat mobile mini-applicationother

Sexual health education and the role of PrEP